Atlas Trials

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Clinical trial NCT02637557 · COMPLETED

Trial details

NCT number
NCT02637557
Sponsor
Ironwood Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2016-03-01
Primary completion
2017-04-26
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.